» Articles » PMID: 28930128

Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such As MicroRNAs

Overview
Specialty Pharmacology
Date 2017 Sep 21
PMID 28930128
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

: Traditional Chinese Medicine (TCM) with its focus on herbal use is popular and appreciated worldwide with increased tendency, although its therapeutic efficacy is poorly established for most herbal TCM products. Treatment was perceived as fairly safe but discussions emerged more recently as to whether herb induced liver injury (HILI) from herbal TCM is a major issue; : To analyze clinical and case characteristics of HILI caused by herbal TCM, we undertook a selective literature search in the PubMed database with the search items Traditional Chinese Medicine, TCM, alone and combined with the terms herbal hepatotoxicity or herb induced liver injury; : HILI caused by herbal TCM is rare and similarly to drugs can be caused by an unpredictable idiosyncratic or a predictable intrinsic reaction. Clinical features of liver injury from herbal TCM products are variable, and specific diagnostic biomarkers such as microsomal epoxide hydrolase, pyrrole-protein adducts, metabolomics, and microRNAs are available for only a few TCM herbs. The diagnosis is ascertained if alternative causes are validly excluded and causality levels of probable or highly probable are achieved applying the liver specific RUCAM (Roussel Uclaf Causality Assessment Method) as the most commonly used diagnostic tool worldwide. Case evaluation may be confounded by inappropriate or lacking causality assessment, poor herbal product quality, insufficiently documented cases, and failing to exclude alternative causes such as infections by hepatotropic viruses including hepatitis E virus infections; : Suspected cases of liver injury from herbal TCM represent major challenges that deserve special clinical and regulatory attention to improve the quality of case evaluations and ascertain patients' safety and benefit.

Citing Articles

Advances, challenges and future applications of liver organoids in experimental regenerative medicine.

Gong D, Mo J, Zhai M, Zhou F, Wang G, Ma S Front Med (Lausanne). 2025; 11:1521851.

PMID: 39927267 PMC: 11804114. DOI: 10.3389/fmed.2024.1521851.


AI empowering traditional Chinese medicine?.

Song Z, Chen G, Chen C Chem Sci. 2024; .

PMID: 39355231 PMC: 11440359. DOI: 10.1039/d4sc04107k.


Elucidation of the relationship between evodiamine-induced liver injury and CYP3A4-mediated metabolic activation by UPLC-MS/MS analysis.

Peng T, Rao J, Zhang T, Wang Y, Li N, Gao Q Anal Bioanal Chem. 2023; 415(23):5619-5635.

PMID: 37433953 DOI: 10.1007/s00216-023-04831-3.


Characteristic analysis of clinical trials for new traditional Chinese medicines in mainland China from 2013 to 2021.

Zhou Y, Yang J, He Y, Lv Y, Wang C, Deng H Front Med (Lausanne). 2022; 9:1008683.

PMID: 36330068 PMC: 9622921. DOI: 10.3389/fmed.2022.1008683.


Anti-Inflammatory and Antioxidant Properties of Carvacrol and Magnolol, in Periodontal Disease and Diabetes Mellitus.

Potra Cicalau G, Babes P, Calniceanu H, Popa A, Ciavoi G, Iova G Molecules. 2021; 26(22).

PMID: 34833990 PMC: 8623889. DOI: 10.3390/molecules26226899.


References
1.
Senior J . Evolution of the Food and Drug Administration approach to liver safety assessment for new drugs: current status and challenges. Drug Saf. 2014; 37 Suppl 1:S9-17. PMC: 4212154. DOI: 10.1007/s40264-014-0182-7. View

2.
Chan K . Chinese medicinal materials and their interface with Western medical concepts. J Ethnopharmacol. 2004; 96(1-2):1-18. DOI: 10.1016/j.jep.2004.09.019. View

3.
Teschke R, Zhang L, Melzer L, Schulze J, Eickhoff A . Green tea extract and the risk of drug-induced liver injury. Expert Opin Drug Metab Toxicol. 2014; 10(12):1663-76. DOI: 10.1517/17425255.2014.971011. View

4.
Teschke R, Schulze J . Risk of kava hepatotoxicity and the FDA consumer advisory. JAMA. 2010; 304(19):2174-5. DOI: 10.1001/jama.2010.1689. View

5.
Su Y, Chen X, Jiang Z, Wang T, Wang C, Zhang Y . A panel of serum microRNAs as specific biomarkers for diagnosis of compound- and herb-induced liver injury in rats. PLoS One. 2012; 7(5):e37395. PMC: 3356255. DOI: 10.1371/journal.pone.0037395. View